Retinol Binding Protein-4 and Adiponectin Levels in Thyroid Overt and Subclinical Dysfunction

Area of Science:

• Endocrinology
• Metabolic Research
• Thyroidology

Background:

• Thyroid dysfunction significantly alters intermediary metabolism.
• Adipocytokines, such as retinol binding protein-4 (RBP-4) and adiponectin, are key regulators of metabolic function.
• Understanding the role of these adipocytokines in thyroid disease is crucial for metabolic health.

Purpose of the Study:

• To investigate serum RBP-4 and adiponectin levels in patients with clinical and subclinical hyperthyroidism and hypothyroidism.
• To compare these levels with euthyroid controls.
• To assess changes in RBP-4 and adiponectin levels before and after thyroid hormone normalization therapy.

Main Methods:

• Recruited 150 patients with thyroid dysfunction (65 hyperthyroid, 85 hypothyroid) and 28 euthyroid controls.
• Measured anthropometric, biochemical (including insulin), and hormonal (free T4, free T3, TSH) parameters.
• Quantified serum RBP-4 and adiponectin using commercial ELISA kits.

Main Results:

• Baseline RBP-4 levels were significantly higher in patients with clinical hypothyroidism compared to controls.
• Serum RBP-4 levels decreased significantly after normalization of thyroid hormone levels in both hyperthyroid and hypothyroid patients.
• No significant changes in adiponectin levels were observed across the studied groups.

Conclusions:

• Elevated RBP-4 levels are associated with hypothyroidism and normalize with thyroid hormone rebalancing.
• RBP-4 may play a role in the metabolic disturbances observed in thyroid dysfunction.
• Adiponectin levels do not appear to be significantly affected by thyroid status in this study.